-
adrenaline
indications
anaphylaxis or severe allergic reaction
Severe life threatening bronchospasam or silent chest pt must only be able to speak single words + or haemodynamic compromise + or ALOC
Bradycardia with poor perfusion unresponsive to atropine + or TCP
Cardiac arrest
Croup with stridor at rest
Shock unresponsive to adequate fluid resuscitation excluding haemorrhagic cause
-
adrenaline
contraindications
ksar
-
adrenaline
precautions
hypovolaemic shock
hypertension
pt taking monoamine oxidase inhibitors (MAOI`s)
-
adrenaline
side effects
anxiety
hypertension
tachyarrhythmias / palpatations
pupil dilation
-
adrenaline
presentation
1mg / 1 ml amp 1:1000
1mg / 10 ml amp + mini jet 1:10 000
-
adrenaline
route
Neb
IM
IV
IO
-
adrenaline
onset, duration, half life
- onset
- 30 secs IV , 60 secs IM
-
adrenaline
adult dose IM
anaphylaxis or severe allergic reaction
IM 500mcg repeated at 5 mins if no improvement as per ARC guide lines
-
adrenaline
adult dose NEB
anaphylaxisis or severe allergic reaction
5mg neb single dose only
may be given for minor face or tounge swelling thought to be allergic in origin. If stridor presemt IM adrenaline must be given.
-
adrenaline
adult dose IV / IO
anaphylaxisis or severe allergic reaction
IV / IO.
20 - 50 mcg repeat at 1 min intervals
no maximum dose
-
adrenaline
adult dose IM
IM 500mcg repeated @ 5 mins if no improvement as per ARC guide lines
-
adrenaline
adult dose IV / IO
severe life threatening asthma or silent chest. pt must only be able to speak in single words + or have haemodynamic compromise + or an ALOC
IV / IO 20mcg repeated @ 1 min intervals
no max dose
-
adrenaline
adult dose IV / IO
bradycardia with poor perfusion
unresponsive to atropine + or TCP
- IV / IO 20mcg repeate at 1 min intervals
- no max dose
-
adrenaline
adult dose IV / IO
Cardiac arrest
- IV / IO 1mg repeat at 3-5 min intervals
- no max dose
-
adrenaline
adult dose IV / IO
shock unresponsive to adequate fluid resuscitation excluding haemorrhagic cause
- IV / IO 20 mcg repeat @ 1 mins intervals
- no max dose
-
adrenaline
paedi dose IM
anaphylaxis or severe allergic reaction
IM >6 yrs 300 mcg
< 6 yrs 150 mcg
repeated at 5 mins if no improvement
-
adrenaline
paedi dose Neb
anaphylaxis or severe allergic reaction
Neb 5mg single does only.
may be given for minor face / tongue swelling thought to be allergic in origin. If stridor is present IM / IV adrenaline must be given
-
adrenaline
paedi dose IV / IO
anaphylaxis or severe allergic reaction
- IV / IO 2 mcg /kg
- repeated at 2 min intervals
- no max dose
-
adrenaline
paedi dose IM
severe life threatening asthma or silent chest. pt must only be able to speak in single words + or have haemodynamic compromise + or an ALOC
IM >6 yrs 300 mcg
< 6 yrs 150 mcg
repeated at 5 mins if no improvement
-
adrenaline
paedi dose IV / IO
severe life threatening asthma or silent chest. pt must only be able to speak in single words + or have haemodynamic compromise + or an ALOC
IV / IO 2mcg/kg single dose not to exceed 50mcg
- repeated @ 2min intervals
- no max dose
-
adrenaline
paedi dose IO / IV
cardiac arrest
IO / IV 10mcg/kg
- repeated every 3-5 mins
- no max dose
-
adrenaline
paedi dose
croup with stridor @ rest
5mg neb
single dose only
-
adrenaline
paedi dose IV / IO
shock unresponsive to adequate fluid resuscitation excluding haemorrhagic cause
bradycardia with poor perfusion unresponsive to atropine + or TCP
- IV / IO 2mcg/kg
- single dose not to exceed 50 mcg
repeated @ 2 min intervals
no max dose
-
adrenaline
drug class + schedule
sympathomimetic
1:1 000 s3 therapeutic poison
1:10 000 unscheduled
-
adrenaline
pharmacololgy
- a naturally occurring catecholamine acts on alpha and beta adrenergic receptors
- increase in heart rate b1
- increase contraction force b1
- increase irritability of ventricles b1
- bronchodilation b2
- peripheralvasoconstriction a1
-
adrenaline
metabolism
- symapthetic nerve endings
- mitochondrial breakdown at synaptic level
-
Amiodarone
indications
cardiac arrest (refactory VF or pulseless VT )
-
Amiodarone
contraindications
nil in cardiac arrest
-
Amiodarone
precautions
concomitant use of anti-arrythmic drugs that pro long QT interval
Thyroid disease
-
Amiodarone
side effects
hypotension
bradycardia
nausea / vomiting
peripheral paraesthesia (pins n needles)
-
Amiodarone
presentation
150 mg in a 3 ml amp
-
Amiodarone
drug class + schedule
anti-arrhythmic
s4 restricted drug
-
-
Amiodarone
dose adult
300mg IV / IO slow push over 2 min (2 vials)
repeat once @ 150mg after 5 mins (1 vial)
total max dose = 450mg
-
Amiodarone
paedi dose
IV / IO
5mg/kg slow push over 2 mins
single dose only
prep : take a 20ml syringe , 150mg (3ml) with 12ml glucose 10% (total 15ml) = final solution of 10mg/ml
-
amiodarone
pharmacology
- prolongs duration of the action potential
- reduces conduction across all cardiac cells
-
Aspirin
indications
suspected ACS
acute cardiogenic pulmonary oedema
-
aspirin
contraindications
KSAR to aspirin and other NSAIDs
chest pain associated with psych stimulant overdose
bleeding disorders
current GI bleed or peptic ulcers
pts <12 yrs
-
aspirin
precautions
possible aortic aneurysm or other condition that may require surgery
pregnancy
Hx of GI bleed or peptic ulcers
concomitant anti coagulant therepy excluding clopidogrel
-
aspirin
side effects
epigastric pain / discomfort
nausea / vomiting
gastritis
GI bleed
NSAID induced bronchospasm
-
aspirin
presentation
300mg white tablet
-
aspirin
dose
300mg chewed with sip of water
pts >12 yrs only
if ? ACS or APO give even if pt is pain free
-
aspirin
onset
duration
half life
o= ? 10 mins
d= 1 week antiplatelet effect
h= 3.2 hrs
-
aspirin
drug class + schedule
anti platelet
s2 therapeutic poison
-
aspirin
pharmacology
- inhibits platelet aggregation irreversibly for the life of the platelet.
- prevents platelets from aggregating to exposed collagen fibers at site of vascular injury.
-
ceftriaxone
indications
suspected meningococcal septicaemia (with non blanching petechial + / or purple rash
-
ceftriaxone
contra indications
< 1 month old
KSAR to cephalosporin = <class of β-lactam antibiotics>
KSAR / anaphylaxis to penicillin based drugs (minor rash from penicillin does not contraindicate use of ceftriaxone)
-
ceftriaxone
precautions
nil
-
ceftriaxone
side effects
pain @ IM site
nausea / vomiting
-
ceftriaxone
presentation
1g glass vial
2g glass vial
-
ceftriaxone
drug class + schedule + pharmacology
antibiotic
s4
Pharm: 3rd generation cephalosporin antibiotic with a bactericidal action
-
-
ceftriaxone
dose Adult IM and IV
4g IM deep IM injection
prep: 2x2g vials with 2.4ml water = 4g/4ml =(1g/1ml)
4g IV slow push 3-5 mins
prep: 2x2g vials with 8.4ml water = 4g/10ml <= 400mg/ml>
-
ceftriaxone
dose paedi
- IM: 100mg/kg (>1month old)
- prep:2g with 3.6ml water = 2g/4ml, <5oomg/ml)
- IV: 100mg/kg slowly over 3-5 mins
- prep: 2g with 9.6water = 2g/10ml (200mg/ml)
-
fentanyl
indications
significant pain
sedtion of maintanance of an established ETT
-
fentanyl
contraindications
KSAR or hypersensitivity to fentanyl
GCS under 14
nasal admin : # nose, nasal obstruction
-
fentanyl
precautions
elderly
hypotension
resp tract burns
resp depression /failure
known addiction to narcotics
pts taking monoamine oxidase inhibitors (MAOIs) = <are one of the oldest classes of antidepressants and are typically used when other antidepressants have not been effective>
-
fentanyl
side effects
drowsyness
bradycardia
hypotension
nausea/vomiting
pin point pupils
resp depression
muscular rigidity (resp muscles)
-
fentanyl
presentation
600mcg / 2ml amp for IN
100mcg/2ml amp for IV / IM
-
fentanyl
dose adult IN
1.5mcg/kg intranasal
repeat once at 1mcg/kg after 10 mins
-
fentanyl
adult doses
IM / IV / IO
- IM 25-100mcg repeat up to 50mcg every 10 min
- no max
IV/IO 25-50mcg repeat up to 50mcg every 10 min. no max
-
fentanyl
dose adult
sedation /maitenance of established ETT
IV / IO 25mcg
consider use with midazolam
prn
no max dose
-
fentanyl
paedi dose IN
NASAL pt must be 1yr or over
1.5mcg/kg repeat once @ 1mcg/kg @ 10 mins
total max dose 100mcg
-
fentanyl
class + schedule
narcotic analgesic
s8 controlled drug
-
glucagon
indications
hypoglycaemic with inability to self admin oral glucose
-
-
-
glucagon
side effects
nil
-
glucagon
presentation
1mg powder vial with water
-
glucagon
adult dose
1mg IM single dose only
-
glucagon
paedi dose
> 25kg 1mg IM
<25kg 500mcg IM
single dose only
-
glucagon
class + schedule
hyperglycaemic
s3
-
Glucose 5%
indications
as a vechicle for drug delivery during iv drug infusion
-
Glucose 5%
contraindications
nil
-
Glucose 5%
precautions
hyperglycaemia
-
Glucose 5%
side effects
nil
-
Glucose 5%
presentation
500ml soft infusion pack
-
Glucose 5%
dose
iv infusion max dose 1000ml
-
Glucose 10%
indications
hypoglycaemia unable to self admin oral glucose
-
Glucose 10%
contraindications
nil
-
Glucose 10%
precautions
extravasation may cause tissue/vascular necrosis
-
Glucose 10%
side effects
nil
-
Glucose 10%
presentation
500ml soft infusion pack
-
Glucose 10%
route
IV / IO
-
Glucose 10%
adult dose
150ml IV / IO repeat @ 100ml boluses every 5 mins until BSL > 4
-
Glucose 10%
paedi dose
IV / IO 2.5ml / kg repeat @ 1ml/kg every 5 until BSL >4
-
Glucose Gel
indications
hypoglycaemic pt who can swallow
-
Glucose Gel
contraindications
KSAR
unconscious
pts with swallowing difficulty
pts < 2yrs
-
Glucose Gel
precautions
nil
-
Glucose Gel
side effects
nausea
d+v
-
Glucose Gel
presentation
15g tube
-
Glucose Gel
dose`s
adult + paedi over 2 yrs old
15g repeat once @ 15 mins if BSL <4
max dose 30g
-
GTN
indications
ACS
APO cardiogenic
autonomic dysreflexia with bp 160 or over
irukandji syndrome with bp 160 or over
-
GTN
contraindications
KSAR
heart rate <50 or >150
bp <100
CVA
head trauma
erectil dysfunctiom drugs in last 24 hrs
-
GTN
precautions
inferior AMI
cerebral vascular disease
risk of hypotension / syncopy
intoxication
erectile drugs in last 4 days
-
GTN
side effects
dizzyness
hypotension
syncopy
tachycardia
headaches
-
GTN
presentation
600mcg tablet
-
GTN
Onset Duration Half life
O= < 2min
D= 20-30 mins
H= 5.5 mins
-
GTN
doses
300 - 600mcg repeat every 5 mins
no max dose
-
GTN
class and schedule
vasodilator
s3
-
GTN
pharmacology
- ia a potent vasodilator that decreases preload and after load
- causes venous pooling of blood
- vasodilation of coronary arteries helps with blood flow to the heart
-
hydrocortisone ICP
indications
modorate or severe asthma
exacerbation of COAD with evidence of rep distress
anaphylaxis or severe allergic reaction requiring adrenaline
symptomatic adrenal insuffciency with hx of addison disease,congenital adrenal hyperplasis,pan-hypopituitarisim or long term steroid administration
-
hydrocortisone ICP
contrindications
KSAR
-
hydrocortisone ICP
precautions
hypertension
-
hydrocortisone ICP
side effects
nil
-
hydrocortisone ICP
presentation
100mg vial
-
hydrocortisone ICP
route
IM
IV
-
hydrocortisone ICP
onset duration halflife
O=1-2 hrs
D= 6-12 hrs
H= 6-8 hrs
-
hydrocortisone ICP
adult dose
asthma / COAD / anaphylaxis
200mg IM or IV
single dose only
-
hydrocortisone ICP
adult dose
adrenal insufficiency
100mg IM / IV single dose only
-
hydrocortisone ICP
paedi dose (all indications)
5mg/kg IV / IM
single dose only
not to exceed 100mg
-
hydrocortisone ICP
claas + schedule
cortico steriod
s4
-
hydrocortisone
pharmacology
an adrenocortical steroid that produces anti-inflammatory response
inhibits inflammatory cells gathering inflammation sites
prevents and suppresses cell mediated immune reactions
-
Ipratropium bromide
indications
severe asthma or silent chest : pt only able to speak single word + or have haemodynamic compromise + or an ALOC
-
Ipratropium bromide
contra indications
KSAR to anticholineergis
pt`s under 2yrs
-
Ipratropium bromide
precautions
glaucoma
prostatic hypertrophy
-
Ipratropium bromide
side effects
dry mouth
dilated puplis
palpitations
-
Ipratropium bromide
presentation
250mcg/1ml nebule
-
Ipratropium bromide
onset / duration / halflife
O=1-3mins peaks in 1-2hrs
D=4-6 hrs
H= 2 hrs
-
Ipratropium bromide
route
neb
-
Ipratropium bromide
adult dose
500mcg neb (2 vials)
single dose only
-
Ipratropium bromide
paedi dose
250 mcg neb ( 1 vial)
single dose only
pt must be over 2 yrs
-
Ipratropium bromide
class + schedule
anticholinergic
s4
-
Ipratropium bromide
pharmacology
antimuscarinic agent that promotes broncodilation by inhibiting broncomotor tone
-
Methoxyflurane
indications
pain
-
Methoxyflurane
contraindications
KSAR
pts under 5 yrs
pre eclampsia
concurrent use of tetracyline antibiotics
Hx severe liver or renal disease
Hx malignant hyperthermia
-
Methoxyflurane
precautions
ALOC
intoxicated or drug effected pt
-
Methoxyflurane
presentation
3ml bottle
-
methoxyflurane
side effects
ALOC
cough
renal failure -following high dose exposure
-
Methoxyflurane
adult dose
3ml repeat @10 mins
max dose 6ml
-
Methoxyflurane
paedi dose
pt`s over 5 yrs
3ml
single dose only
-
metoclopramide
indications
nausea / vomiting
Hx nausea vomting with narcotic use or motion sickness
spinal injury
air med evac
-
metoclopramide
contraindications
KSAR
pt`s under 12
Hx of dystonic reactions
Gi haemorrhage
bowel obstruction or perforation
not to be given with in 6 hrs of phenothiazines eg stemitil
-
metoclopramide
precautions
undiagnosed abdo pain
-
metoclopramide
side effects
drowsiness
dry mouth
dystonic reaction
oculogyric crisis
-
metoclopramide
presentation
10 mg in a 2ml amp
-
metoclopramide
onset duration half life
O=1-3 IV, 10- 15 IM
D= 1-2 hrs
H= 2-5 hrs
-
metoclopramide
dose
10mg IM / IV
single dose only
-
metoclopramide
class + schedule
anti emetic
s4
-
Midazolam
indications
sezures / convultions
sedation for :
matainence of established ETT
severely agitated pt -not due to pain
agitated head injury
proceducres TCP / cardioversion
ketamine -agitated emergence
-
Midazolam
contraindications
KSAR to benzodiazepines
pt`s restrained in prone position
-
Midazolam
precautions
pt`s that are elderly or chronic renal failure ,CCF or shock may require lower doses
COAD -may cause sevsere resp depression
multiple sclerosis
myasthenia gravis <neuromuscular disease>
-
Midazolam
side effects
respiratory depression -esp with intox or narcotic
hypotension
-
Midazolam
presentation
5mg / 1ml amp
-
Midazolam
onset duration halflife
O=1-3 min IV , 5-15 IM
D=variable
H= 2.5 hrs
-
-
Midazolam
adult dose seizure
IN: 5mg prn @ 2min max dose 10mg
IM: 5mg prn @ 2min max dose 20mg
IV: 2.5mg prn @ 5min no max dose
IO 4 ICP: 1-2.5mg prn @ 5min no max dose
-
Midazolam
adult dose
sedation 4 maintenance of ETT
IV / IO 1 - 2.5mg
consider with morph /fentanyl
repeat prn
max dose 20mg
-
Midazolam
adult dose
agitated head injury
IV / IO up to 2.5mg prn @ 5 mins
max 20mg
-
Midazolam
adult dose
sedation TPC ot Cardioversion
1mg prn @ 2min
max 20mg
-
Midazolam
adult dose
severly agitated pt - not due to pain
IM up to 5mg prn @ 10 mins max 20mg
IV up to 2.5mg prn @ 5mins max 20mg
-
Midazolam
adult dose
ketamine emergence
up to 2.5mg IV
max dose 5mg
-
midazolam
paedi dose
seizures
NAS : 5mg prn @ 2mins, max dose 10mg
IM : 200mcg/kg (single dose not above 5mg) repeat @ half initial dose (max 2.5mg) @ 10 mins -- no max dose
IV / IO : 100mcg/kg single dose not to exceed 2.5mg. repeat @ 5min intervals--- no max dose
-
midazolam
paedi dose
ketamine disinhibition
IV / IO 50mcg/kg
single dose not exceed 2.5mg
repeat after 5mins
total max 5mg
-
midazolam
paedi dose
sedation/maintenance of ETT
IV / IO up to 100mcg/kg
- single dose not above 2.5mg
- consider with morphine
- repeated after 5mins
- no max dose
-
midazolam
paedi dose
head injury / agitated
consult needed
IM / IV / IO 100mcg/kg
single dose not over 2.5mg
- repeat after 5mins
- total max 5mg
-
midazolam
drug class / schedule / presentaion
class: benzodiazepine
sched: s4 restricted drug
pres: 5mg / 1ml amp
-
midazolam
pharmacology and metabolisim
- a short acting CNS depressant that induces
- amnesia, anesthesia,hypnosis and sedation by enchaaning the action of GABA. Depresent effects all levels of the CNS
metabolised by the liver and excreted by the kidneys
-
midazolam
onset / duration / half life
O: 5-15 min IM and 1-3 mins IV
D: variable
H : 2.5 hours
-
Morphine
indications
significant pain
autonomic dysreflexia with b/p 160 or over
sedation for maintenance of an ETT
-
morphine
contra indications
KSAR
-
morphine
precautions
elderly pt`s
hypotension
resp depression / failure
resp tract burns
known addiction to narcotics
pt`s on MAOIs
-
morphine
side effects
bradycardia
drowsiness
hypotension
nausea / vomiting
rep depression
pin point pupils
-
morphine
adult dose
significant pain and autonomic dysreflexia
IM IV IO
IM : up to 10mg repeated up to 5 mg @ 10 mins max dose 20mg
IV : up to 5 mg repeat up to 5mg every 5mins tritating to pt responce no max dose
IO : 2.5 - 5mg repeat up to 5mg every 5mins titrate to pt responce no max dose
-
morphine
adult dose
sedation for maintenance of an ETT
IV / IO : 2.5mg consider with midazolam repeat prn
no max dose
-
morphine
paedi dose
pain / autonomic dysreflexia
IM IV IO
IM over 1 yr old : 100--200mcg/kg single max dose 5mg -total max dose 200mcg/kg
IV IO over 1 yr old : 100mcg/kg single max dose 2.5mg repeat 50mcg/kg max 2.5mg @ 10 min intervals no max dose.
-
morhpine
paedi dose
maintenance of ETT
- IV IO : over 1yr , 100mcg/kg
- single dose not above 2.5mg consider with midazolam, no max dose
-
morhpine
drug class / schedule / presentation
class: narcotic analgesic
sched: s8 controlled drug
Pres: 10mg / 1ml amp
-
morphine
pharmacology / metabolism
- narcotic analgesic acts on the CNS by binding to opioid receptors altering the pain perception and emotional response to pain
- causes resp depression
- decrease in gag reflex
- decrease in av node conduction
- vasodialation
- meabolised by liver,kidney and lungs.
-
naloxone
indications
respiratory depression secondary to narcotics use
-
naloxone
contraindications
KSAR
-
naloxone
precautions
pt`s with pre existing cardiac disease
-
naloxone
side effects
- combativeness
- vomiting
- sweating
- tachycardia
- hypertension
- convulsions
- pulmonary
- oedema
-
-
naloxone
adult dose
IM : 800mcg (2 amps) prn tritating to pt and airway max dose 4mg
- IV IO : 50mcg prn tritating to pt and airway
- no max dose
-
naloxone
paedi dose
IM IV IO
IM : 20mcg/kg single dose only not to exceed 800mcg
- IV IO : 20mcg/kg tritating to pt`s responce
- no max dose
-
naloxone
drug class / schedule / metabolisim /
presentation
class : opioid antagonist
sched: s4 restricted drug
metab: hepatic
pres: 400mcg/1ml amp
-
ondansetron
indications
nausea / vomiting
prophylactic use for pt`s who previously experienced nausea/vomiting with narcotics
spinal injury
aero med evacuations
-
ondansetron
contraindications
pts under 3 yrs
KSAR
-
ondansetron
precautions
hepatic liver impairment
intestinal obstruction
-
ondansetron
side effects
headache
constipation
dysrrythmias
skin flushing / sense of warmth
extrapyramidal effects (slow movement /tremours/stiffness/ repetative movements )
-
ondansetron
presentation and route
4mg wafer
orally disintegrating tablet -place directly on top of tongue will dissolve in seconds water not nessesary
-
ondansetron
adult dose and paedi dose
adult: 4mg single dose only
paedi: over 3 yrs 2mg single dose only
-
ondansetron
class / schedule / metabolism
class : anti emetic
sched: s4 restricted drug
metab: liver excreted by kidneys
-
paracetamol
indications
minor pain and fever
-
paracetamol
contraindications
KSAR
pt`s under 25kg (6yr old)
-
paracetamol
precautions
hepatic or renal dysfunction
pt`s on anticoagulant medications
-
paracetamol
side effects
nausea
-
paracetamol
adult dose
0.5g -- 1gram
repeated every 4 hrs
total max dose 4 gram in 24hrs
-
paracetamol
paedi dose
25kg or over (6yrs)
20mg/kg
single dose only
must not be given within 4 hrs of previous paracetamol
-
paracetamol
drug class / pharmacology / metabolism /
schedule
class : analgesic
pharm: p-aminophenol derivative that produces analgesic and antipyretic effects -it does not possess significant anti-inflammatory activity
metab: hepatic excreted by kidneys
sched: s4 restricted drug
-
salbutamol
indications
bronchospasm
hyperkalaemia with widening QRS and or AV dissociation
-
salbutamol
contraindications
KSAR
pt`s under 2yrs
-
salbutamol
precautions
APO
ischaemic heart disease
-
salbutamol
side effects
anxiety
tachy arrhythmia's
tremors
hypokalaemia + metabolic acidosis
-
salbutamol
adult dose and paedi dose
bronchospasm: 5mg neb prn no max dose
hypokalaemia ; 10mg neb repeated once only
PAEDI asthma only : >2ys 5mg neb prn no max dose
-
salbutamol
class / metabolism / schedule
class: beta-adrenalic agonist
met : hepatic excreted by kidneys
sched : s4 restricted drug
-
salbutamol
pharmacology
is a direct acting sympathomimetic mainly effects beta 2 adrenoceptors. primarly acts as a bronchodilator but also has inotropic and chronotropic actions.lowers serum potassium levels thru direct stimulation of of sodium/potassium pump drawing potassium into cells
-
sodium bicarbonate 8.4%
indications
significant injury with potential for crush injury
cardiac arrest : > 15mins duration
TCA OD : (tricyclic anti depressant) with prolonged QRS.QT interval or seizures
? hyperkalaemia: (widening QRS / or AV discossiation)
-
sodium bicarbonate 8.4%
contraindications
nil
-
sodium bicarbonate 8.4%
precautions
sodium bicarbonate 8.4% in paedi resus may worsen respiratory acidosis
-
sodium bicarbonate 8.4%
side effects
cerebral oedema
congested heart failure
-
sodium bicarbonate 8.4%
presentation
100ml bottle
-
sodium bicarbonate 8.4%
class / metabolism / schedule
class: alkalising agent
metabolised to Co2 + water
sched: unscheduled
-
sodium bicarbonate 8.4%
adult doses
all indications
IV / IO : 100ml single dose only
nb: injury with potential for crush for para 1
all other indications para 3 only
-
sodium bicarbonate 8.4%
paedi dose
IV / IO : 1ml/kg
single dose only
-
sodium bicarbonate 8.4%
pharmacology
- hypotonic alkalizing solution helps combating acidosis.
- bicarbonate ion combine with hydrogen ion to form carbonic acid,which dissociates to carbon dioxide and water.
- during administration the hydrogen ion levels in plasma falls ,further hydrogen comes out of the cells. To persevere electrical neutrality potassium moves into the cells thus reducing hyperkalaemia.
- h+hco3 <-----> h2oco2 <---> co2 + h2o
-
sodium chloride 0.9%
indications
hypovolaemic shock :
cardiogenic shock :inadequate tissue perfusion
burns : deep / full / >15%
flush:
dissolve / dilute drugs : IM / IV / IO
-
sodium chloride 0.9%
contraindications
nil
-
sodium chloride 0.9%
precautions
pt`s with hx /acute heart failure
renal failure
uncontrolled bleed : unless associated with severe head injury
-
sodium chloride 0.9%
pharmacology
isotonic crystalloid, electrolyte replenisher for maintenance or replacement of fluid deficits
-
sodium chloride 0.9%
special notes
uncontrolled haemorrhage use to maintain a radial pulse
traumatic brain injury use to maintain systolic bp of 100-120/p in adult
reassess every 250--500ml
-
atropine
indications
bradycardia: with poor perfusion pre adrenaline
envenomation: with increased parasympathetic activity
organophospahate toxicity: with cardiac or resp compromise
hypersalivation : with ketamine use
-
atropine
contraindications
KSAR
-
atropine
precautions
atrial flutter
atrial fibrillation
AMI
glucoma
-
atropine
side effects
agitation
hallucinations
dilated pupils
dry mouth /skin
reduced broncho + gastric secretions
tachycardia
-
atropine
presentaion
600mcg/1ml amp
-
atropine
drug class
antichlinergic (antimuscarinic)
-
atropine
pharmacology
- inhibits the action of the parasympathetic nervous system.
- blocks the action of vagus nerve of the heart
- increase rate of SA node
- increases conduction thru AV node
- blocks exocrine gland acitvity
-
atropine
adult dose
bradycardia poor perfusion
IV / IO : 600mcg repeated once @ 2min
max dose 1.2mg
-
atropine
adult dose
envenomation and organophosphate poisioning
IM IV IO : 1.2mg (2 amps)
repeat at 5 min intervals
no max dose
-
atropine
adult dose
hypersalivation
IV IO : 600mcg
single dose only
-
atropine
paedi dose
bradycardia poor perfusion
IV IO : 20mcg/kg single dose not above 600mcg ( 2 amps)
repeat once
total max dose 40mcg/kg
-
atropine
paedi dose
envenomation and organophosphate
IM IO IV :
20mcg/kg
repeat @ 5min intervals
no max dose
-
atropine
paedi dose
hypersalivation
IV IO : 20mcg/kg
single dose only - not to exceed 600mcg ( 2 amps)
-
atropine
onset / duration / half life
O: 1-2 min peaks 15-20min
D: up to 5 hrs
H: 3-4 hrs
-
calcium gluconate 10%
drug class / presentation / schedule /
metabolisim
class: electrolyte
pres: 0.953gram / 10ml amp
sched: unscheduled
met: renal glomeruli reabsorbs most of it,remained excreted by faeces
-
calcium gluconate 10%
indications
hyperkalaemic cardiac arrest:
severe hyperkalaemia: with haemodynamic compromise + or cardiac rhythm disturbance
calcium channel blocker toxicity:
hypotension assoc with magnesium infusion: that fails to respoond to IV fluids
-
calcium gluconate 10%
contraindications
KSAR
digoxin OD
-
calcium gluconate 10%
precautions
respiratory acidosis
-
calcium gluconate 10%
side effects
cardiac arrest : nil
- all other indications :
- syncope
hypotenision
bradycardia
cardia dysrrhythmias
cardiac arrest
-
calcium gluconate 10%
adult dose :all indications
IV IO: 10ml slow push over 2mins
repeat once @ 10mins
-
calcium gluconate 10%
paedi dose all
IV IO:
0.2ml/kg
slow push over 2mins
repeat once @ 10min
-
calcium gluconate 10%
pharmacology
- electrolyte that plays role in muscular and neural systems.
- involved in skeletal muscle contractions,excites coupling in cardiac and smooth muscle
- intracellular 2nd messenger
- these effects combine to exert a positive inotropic effect in cardiac arrest pt`s
- has a role in cardiac membrane stabilisation in hyperkalaemia
-
frusemide
pharmacology and drug class
loop diuretic inhibits sodium and chloride absorption in the ascending loop of henle. (proxmial and distal tubes)
-
frusemide
indications
Congestive Cardiac Failure
fluid overload
oliguria: after correction of hypotension and hypovolaemia
-
frusemide
contraindications
KSAR
pt`s under 12yrs
-
frusemide
precautions
hypotension
-
frusemide
side effects
can lead to hypotension
potassium loss may cause dysrrhythmias
-
frusemide
presentation
20mg / 2ml amp
-
frusemide
onset / duration / half life / schedule
O: 3-5mins peals in 30 min
D: 2hrs
H: 100 mins
Sched: s4
-
frusemide
dose adult only
IV : 40mg (2 amps) consider repeat @ 5min
max total 80mg (4 amps)
-
ketamine
indications
pain : servere burns following morphine
- : multipal or significant #`s (requiring extraction) post morphine up to 0.3mg/kg
-
- :# reduction / splinting (post morphine)
-
ketamine
contraindications
KSAR
Pt`s under 5yrs
GCS 12 or under
ACS
hypertension: sbp of 180 or over or dbp of 110 or over
known hydrocephalus or raised intra-ocular pressure
-
ketamine
precautions
pt`s over 65yrs
pt`s had midazolam or other CNS depressents
hypovolaemia : exaggerated effects n delayed onset
globe injury: eye
complex face injury / #s
impaired resp fuction
psychotic symptoms in pt`s
-
ketamine
side effects
dissociation / trance like state
nystagmus
disinhibition
emergance: 10% more in adults
hypertension
tachycardia
decrease GCS
hypersalivation
nausea/vomting
laryngospasm
resp depression:rare
-
ketamine
presentation
200mg / 2ml vial
-
ketamine
adult dose
IV IO : 10-20mg repeated every 2-3 mins
total max dose 1mg/kg
prep: mix 1 vial (200mg/2ml) with 18ml saline in 20ml syringe = 10mg/ml
-
ketamine
paedi dose
IV IO: 1yr or above 100mcg/kg (0.1mg/kg)
repeat every 2-3 mins
total max dose 1mg/kg
- prep: mix 1 vial (200mg/2ml) with 18ml saline in 20ml syringe =10mg/ml
- expel 18ml then dilute with another 18ml saline = 1mg/ml
-
ketamine
drug class
anesthetic
analgesic
-
ketamine
metabolism
hepatic ~ 90% excreted in urine as metabolites
-
ketamine
pharmacology
- anaesthetic agent acts as NMDAreceptor antagonist.
- at low doses =significant analgesia preserves resp drive + airway reflexes
- minimal haemodynamic compromise as acts as sympathomimetic agent
- may result transient hypertension + tachycardia
- pt may have issues with perception/dis-inhibition or emergence reaction
-
Lignocaine 2%
indications
Conscious VT : with out haemodynamic compromise
To reduce pain with ezyIO drug/fluid administration: when pt not in cardiac arrest
local anaesthesia:
-
Lignocaine 2%
contraindications
KSAR
bradicardia
current heart failure
heart block or conduction defects
Torsades de Pointes
-
Lignocaine 2%
precautions
hypotension + poor pefusion in conscious VT
-
Lignocaine 2%
side effects
convulsions
hypotension
nausea
tinnitus
-
Lignocaine 2%
presentaion
100mg / 5ml amp
-
-
Lignocaine 2%
adult dose
conscious VT
IV : 1-1.5mg/kg slow push over 2 mins
repeat once at half inital dose @ 10 min
total max dose 300mg
-
Lignocaine 2%
adult dose
EZ-IO
IO : 60mg - (40mg then rapid 10ml flush,followed by another 20mg)
total max 60mg
-
Lignocaine 2%
paedi dose
EZY IO
IO: 1mg/kg single dose only
max dose 20mg
-
Lignocaine 2%
drug class
anti-arrhythmic
local analesthetic
-
Lignocaine 2%
pharmocology / metabolisim
- sodium channel blocker
- stabilises all excitable membranes and prevents the transmission of nerve impulses
- decreases cardiac muscle + conduction velocity thru AV node.
also a local anaesthetic
metabolisim: 80% by the liver remainder by kidneys
-
Lignocaine 2%
onset / duration / halflife /schedule
O: 1-2 mins
D: 20-30 mins
H: 1-2 hrs
Sced: s4 restricted drug
-
magnsuim sulphate
indications
box jelly fish sting: unresponsive to viniger,ice,narcotics
Eclampisa:
Life threatening asthma: only in py`s requirng IM/IV adrenaline
Torsades de Pointes:
Irukandji sting: bp>160 pain unrekieved with narcotics
-
magnsuim sulphate
contraindications
KSAR
Heart block
Renal failure
-
magnsuim sulphate
precautions
renal impairment
-
magnsuim sulphate
side effects
pain @ IV site
magnesium toxicity: = hypotension,resp depression/loss of tendon reflexes
-
magnsuim sulphate
presentaion
10mmol (2.47g) in 5ml ampoule
-
magnsuim sulphate
adult dose
asthma
IV IO: 10mmol slow push over 10min
single dose only
-
magnsuim sulphate
adult dose
Torsades de pointes
IV IO: 10mmol slow push over 10min
repeat once @ 10mins
total max dose 20mmol
-
magnsuim sulphate
adult dose
irukandji syndrome / eclampsia
IV IO: 20mmol slow push over 10mins
repeat once if indicated at 10mins
-
magnsuim sulphate
adult dose
box jelly fish
IV IO: 20mmol slow push over 10mins
single dose only
-
magnsuim sulphate
paedi dose
life threat asthma
IV IO: 0.1mmol/kg
- round up to nearest .05mmol
- slow push over 10mins
single dose only not to exceed 5mmol
-
magnsuim sulphate
paedi dose
torsades de pointes
IV IO: 0.1mmol/kg
- round up to nearest 0.5mmol
- slow push over 10mins
- single dose not to exceed 5mmol
- repeat once @ 10mins
total max dose 10mmol
-
magnsuim sulphate
paedi dose
box jelly / irukandji
- IV IO: 0.1mmol/kg
- round up to nearest 0.5mmol
slow push over 10mins
single dose not to exceed 5mmol
repeat once @ 10mins
total max dose 10mmol
-
magnsuim sulphate
drug class / metabolisim
Class: electrolyte
Met: excreted mostly in urine small amounts in faeces and saliva
-
magnsuim sulphate
pharmocolgy
causes vasodilation / bronchodilation thu inhibition of smooth muscle contraction
also has anticonvulsant and anit-dysrrhythmic properties
-
weight calculation
paedi
age x 3 + 7 =kg
|
|